BioPharmSignal logoBioPharmSignal

Biotech News

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

Lucid Diagnostics (LUCD)Lucid DiagnosticsFinancing

LUCD (LUCD) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is lucd.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

IDYAIDEAYA Biosciences2026-06-10 20:05 EST

IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares

RLAYRelay Therapeutics2026-05-21 00:21 EST

Relay Therapeutics Announces Pricing of Public Offering of Common Stock

RLAYRelay Therapeutics2026-05-19 20:03 EST

Relay Therapeutics Announces Proposed Public Offering of Common Stock

LUCDLucid Diagnostics2026-05-14 12:00 EST

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

LEGNLegend Biotech Corporation2026-06-18 01:21 EST

Legend Biotech Corporation Announces Pricing of Public Offering

LEGNLegend Biotech Corporation2026-06-17 20:29 EST

Legend Biotech Corporation Announces Proposed Public Offering

SNDXSyndax Pharmaceuticals2026-06-04 11:00 EST

Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes

DGXQuest Diagnostics2026-06-29 12:16 EST

Quest Diagnostics Foundation Commits Nearly $5 Million to Improving Health Outcomes and Food Security in Miami-Dade County, Florida

View all latest news

Lucid Diagnostics

Lucid Diagnostics is a cancer diagnostics company focused on early detection and screening for esophageal disease. Its business is centered on helping identify cancer risk earlier through testing.

Recent company news

LUCDLucid Diagnostics2026-05-14 12:00 EST

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

LUCDLucid Diagnostics2026-04-30 12:31 EST

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

LUCDLucid Diagnostics2026-04-24 14:23 EST

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

LUCDLucid Diagnostics2026-04-23 12:30 EST

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

LUCDLucid Diagnostics2026-04-09 12:01 EST

Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

Stock data

Close
0.90 USD
Market cap
196.48M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States